[go: up one dir, main page]

AU2001235442A1 - Oral delivery of allergens in milk - Google Patents

Oral delivery of allergens in milk

Info

Publication number
AU2001235442A1
AU2001235442A1 AU2001235442A AU3544201A AU2001235442A1 AU 2001235442 A1 AU2001235442 A1 AU 2001235442A1 AU 2001235442 A AU2001235442 A AU 2001235442A AU 3544201 A AU3544201 A AU 3544201A AU 2001235442 A1 AU2001235442 A1 AU 2001235442A1
Authority
AU
Australia
Prior art keywords
allergens
milk
oral delivery
oral
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001235442A
Inventor
Heinz Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis Nutrition AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Nutrition AG filed Critical Novartis Nutrition AG
Publication of AU2001235442A1 publication Critical patent/AU2001235442A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Medicinal Preparation (AREA)
AU2001235442A 2000-02-02 2001-01-31 Oral delivery of allergens in milk Abandoned AU2001235442A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0002386.1A GB0002386D0 (en) 2000-02-02 2000-02-02 Therapeutic composition
GB0002386 2000-02-02
PCT/EP2001/001029 WO2001056611A1 (en) 2000-02-02 2001-01-31 Oral delivery of allergens in milk

Publications (1)

Publication Number Publication Date
AU2001235442A1 true AU2001235442A1 (en) 2001-08-14

Family

ID=9884826

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001235442A Abandoned AU2001235442A1 (en) 2000-02-02 2001-01-31 Oral delivery of allergens in milk

Country Status (6)

Country Link
US (1) US20030003133A1 (en)
JP (1) JP2003521524A (en)
AR (1) AR027523A1 (en)
AU (1) AU2001235442A1 (en)
GB (1) GB0002386D0 (en)
WO (1) WO2001056611A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125731A1 (en) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Dosage form of immunological agents
AU2003280324A1 (en) 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
CA2554337A1 (en) 2004-02-06 2005-08-25 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
US7763257B2 (en) * 2004-12-09 2010-07-27 Christina Juneau Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products
US20090258107A1 (en) * 2005-11-14 2009-10-15 Nestec S.A. Oral Tolerance Promotion With Glycated Proteins
WO2007113633A2 (en) * 2006-04-03 2007-10-11 Pfizer Products Inc. Immunogenic compositions comprising cat allergen fel dl
SI2162133T1 (en) 2007-07-09 2016-11-30 Nestec S.A. Methods for reducing allergies caused by environmental allergens
WO2012077076A1 (en) * 2010-12-08 2012-06-14 Holt Patrick G Treating or preventing sensitivity to milk allergens
JP2014520162A (en) 2011-06-23 2014-08-21 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド Materials and methods for modulating immune responses
JP5931449B2 (en) * 2012-01-11 2016-06-08 日東電工株式会社 Pharmaceutical composition and method for producing the same
JO3820B1 (en) 2012-05-03 2021-01-31 Regeneron Pharma Human antibodies to FEL D1 and methods for their use
CA2922113C (en) 2013-08-23 2023-05-23 Regeneron Pharmaceuticals, Inc. Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit)
WO2018118713A1 (en) 2016-12-22 2018-06-28 Regeneron Pharmaceuticals, Inc. Method of treating an allergy with allergen-specific monoclonal antibodies
KR20240096746A (en) 2017-06-01 2024-06-26 리제너론 파마슈티칼스 인코포레이티드 Human antibodies to bet v 1 and methods of use thereof
US11173113B2 (en) 2017-12-06 2021-11-16 Prollergy Corporation Composition and method for reducing allergic response
CA3177918A1 (en) 2020-07-01 2022-01-06 Amanda ATANASIO Methods of treating allergy using anti-bet v 1 antibodies
EP4204449A1 (en) 2020-08-26 2023-07-05 Regeneron Pharmaceuticals, Inc. Method of treating an allergy with allergen-specific monoclonal antibodies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130128A (en) * 1982-06-03 1992-07-14 Stolle Research & Development Corporation Use of honey as vaccine
US5863561A (en) * 1982-06-03 1999-01-26 Stolle Research & Development Corporation Immune suppressive product
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
EP0646017A1 (en) * 1990-07-05 1995-04-05 The Stolle Research And Development Corporation Immune suppressive product
ATE143803T1 (en) * 1992-12-22 1996-10-15 Univ Cincinnati ORAL ADMINISTRATION OF IMMUNOLOGICALLY ACTIVE BIOMOLECULES AND OTHER THERAPEUTIC PROTEINS
JPH07138187A (en) * 1993-11-16 1995-05-30 Nippon Ham Kk Oral immunotolerance, oral rheumatoid arthritis therapeutic agent and functional food

Also Published As

Publication number Publication date
JP2003521524A (en) 2003-07-15
AR027523A1 (en) 2003-04-02
WO2001056611B1 (en) 2002-01-10
US20030003133A1 (en) 2003-01-02
WO2001056611A1 (en) 2001-08-09
GB0002386D0 (en) 2000-03-22

Similar Documents

Publication Publication Date Title
AU2002239397A1 (en) Drug formulation having improved oral tolerability
AU2001235442A1 (en) Oral delivery of allergens in milk
AU2003213683A1 (en) Cleansing compositions with milk protein and aromatherapy
EG23943A (en) Flash-melt oral dosage formulation
AU2002339993A1 (en) P-amidobenzylethers in drug delivery agents
AU2001268743A1 (en) Oral care compositions comprising chlorite and methods
AU2001226029A1 (en) Pharmaceutical formulation and method for pulmonary and oral delivery
AU2001250032A1 (en) Oral care device
AU2001259079A1 (en) Pediatric mattress
AU2001256856A1 (en) Nutritional preparation comprising ribose and folic acid and medical use thereof
EP1391212A4 (en) Oral preparations and supports for oral preparations
EP1383518A4 (en) Oral delivery of macromolecules
AUPQ969800A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2001287898A1 (en) Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AU2002221096A1 (en) Medicinal compositions improved in solublity in water
AU2001250567A1 (en) Combined toothbrush and tongue cleaner
AU2001284444A1 (en) Preparations for oral administration
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU2002306461A1 (en) In vivo delivery methods and compositions
AU2001249338A1 (en) Shampoo chair
AU2002239279A1 (en) Oral nanosphere delivery
AU2002308649A1 (en) Compositions and methods for enhancing drug delivery
AU2002226986A1 (en) In vivo delivery methods and compositions
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2001239954A1 (en) Cleaning compositions and use thereof